Viewing Protocol Section

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT04830215
Ignite Creation Date: 2024-05-06 @ 3:59 PM
Last Modification Date: 2024-10-26 @ 2:01 PM
Study NCT ID: NCT04830215
Protocol Section: NCT04830215
Start Identification Module Data
Expand Identification Module Data
Brief Title: Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder
Official Title: A Phase 4 Multicenter Open-label Interventional Trial to Assess the Effects on Engagement of Flexible-dose Brexpiprazole OPC-34712 as Adjunctive Therapy for the Treatment of Adults With Major Depressive Disorder
Acronym: None
Organization: Otsuka Pharmaceutical Development Commercialization Inc
Organization Class: INDUSTRY
Organization Study ID: 331-201-00289
Start Status Module Data
Status Verified Date: 2023-05
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Otsuka Pharmaceutical Development Commercialization Inc
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Otsuka Pharmaceutical Development Commercialization Inc
Start Oversight Module Data 369050
Description Module: 372550
Study Last Update Post Date Type(Status Module):
Attachment: Upload